Knowledge centers Unlocking the Potential of Flow Chemistry to Transform Pharmaceutical Manufacturing Processes

Unlocking the Potential of Flow Chemistry to Transform Pharmaceutical Manufacturing Processes

15/05/2024

White paper

By Juliette Martin, Scientific Communication Manager

Jean-Yves Lenoir, Manager R&D Flow Chemistry

Jean-Baptiste Rouchet, Technologies Expert

Over the past decade, a profound shift has been underway in the pharmaceutical industry, as continuous flow processes gain momentum alongside traditional batch methods. This transformation is propelled by advancements in flow reactor technology, promising enhanced efficiency, safety, and sustainability in chemical production. In this article, we delve into the transformative power of flow chemistry, exploring its myriad benefits and applications in fine chemicals and active pharmaceutical ingredient (API) manufacturing.

In this white paper you will learn that Flow Chemistry:

Increase Efficiency and Safety by offering continuous processing, leading to faster production times, less waste, and improved safety when handling hazardous materials

Enhance Quality and Control thanks to smaller reaction vessels and precise control over reaction conditions ensure consistent product quality and easier scale-up from lab to production

Has Sustainable Benefits by requiring less solvent, reagents, and energy compared to batch processes, minimizing environmental impact

Drives Innovation and accelerates development stage by integrating rapid experimentation, and can explore novel chemistries

Is a Complementary Approach and won’t replace traditional batch processes entirely. Instead, it offers a valuable tool for specific applications, working alongside existing methods

Download the white paper

Latest news

See all

Expertise / White paper

Unlocking the Potential of Flow Chemistry to Transform Pharmaceutical Manufacturing Processes

/ White paper

Cracking the codes – Adopting Industrial Biocatalysis

From a process chemist point of view, developing an enzymatic process at industrial scale, is very much the same challenges and principles than any other chemical processes strategies. The exception relies however in understanding the behaviour of the biocatalyst for optimal performance and robustness. In this article, we wish to review the key stages that are required for implementing a biocatalytic process at industrial scale, supported by 4 case studies. Because speed matters in industry, we will examine the key highlights for derisking and ensuring cost-effective process at acceptable timelines, whether we are targeting the pharmaceutical, food, fine chemical or commodity industries.

/ Publication

Enantioselective Reduction of Cyclobutenones Using Ene-Reductases

Chiral cyclobutanes are important structural features that are widely present in many biologically active natural and non-natural products. The threedimensional structure of cyclobutanes opens opportunities for applications in medicinal chemistry, and the introduction of this structural motif in smallmolecule drug candidates has been increasing in recent years.

/ Publication

Biocatalysis: a necessary tool for synthetic chemists

For the past decade, the need to produce compounds with more complexity in terms of group functionality and chemical structure has expanded tremendously, including drug discovery in the pharmaceutical field and materials science. Moreover, the increasing pressure to reduce energy consumption, protect the environment and conserve natural resources challenge synthetic methods.